INCY:NASDAQ
Incyte Corp
၁၁၃.၂၉ US$
arrow_upward
+၀.၄၈%(+၀.၅၄) 1D
အောက် ၉, GMT-၄ ၁၅:၀၆:၂၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
၁၁၂.၃၅ US$
High
၁၁၃.၈၇ US$
Low
၁၁၁.၈၀ US$
Mkt. cap
ဋေ ၂.၃၀ ထ
Avg. vol.
၁.၆၀ သန်း
Volume
၅.၆၅ သိန်း
P/E ratio
၁၄.၄၄
52-wk high
၁၃၂.၅၈ US$
52-wk low
၈၂.၈၂ US$
EPS
၇.၈၅ US$
Beta
၀.၇၄
Shares outstanding
၂၀.၂၇ ကုဋေ
No. of employees
၃ ထောင်
Open
၁၁၂.၃၅ US$
High
၁၁၃.၈၇ US$
Low
၁၁၁.၈၀ US$
Mkt. cap
ဋေ ၂.၃၀ ထ
Avg. vol.
၁.၆၀ သန်း
Volume
၅.၆၅ သိန်း
P/E ratio
၁၄.၄၄
52-wk high
၁၃၂.၅၈ US$
52-wk low
၈၂.၈၂ US$
EPS
၇.၈၅ US$
Beta
၀.၇၄
Shares outstanding
၂၀.၂၇ ကုဋေ
No. of employees
၃ ထောင်
News stories
From web sources and news partners
TipRanks
·
ပြီးခဲ့သည့် ၂ နာရီ
Incyte’s Latest Dermal PK Study: What Completed Early-Stage Data Mean for INCY Investors
Yahoo Finance
·
ပြီးခဲ့သည့် ၈ နာရီ
What to Expect From Incyte’s Next Quarterly Earnings Report
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၅ နာရီ
Is Rare Disease Approval Altering The Investment Case For Incyte (INCY)?
GuruFocus
·
ပြီးခဲ့သည့် ၁ ရက်
INCY Maintained by RBC Capital -- Price Target Raised to $114
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees၂.၈၄ ထောင်
Founded၂၀၀၂
HeadquartersWilmington, ဒယ်လာဝဲပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteincyte.com